Company page

Nurix Therapeutics, Inc.

Nurix Therapeutics, Inc. is a public biotechnology company based in America, trading under the ticker NRIX. The company focuses on developing innovative therapies for cancer and other diseases by harnessing the power of targeted protein modulation. With a market capitalization of approximately $1.81 billion, Nurix is positioned to make significant contributions to the field of therapeutics.